Position
Fidelity in Relay Therapeutics, Inc.
Back to the book · All holders of RLAY
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $32.4M$9.95 → $18.71
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 162.2K | $1.37M | — | — | — | 0.0% |
| Q1 2026 | 3.7M | $36.8M | $9.95 | $241.7K | $35.2M | 0.0% |
| Q2 2026 | 20.1M | $376.3M | $18.71 | $32.4M | $307.1M | 0.0% |